ICON has signed an extension to its strategic agreement with Lilly to manage the company’s clinical data outside the U.S. ICON will now also oversee Lilly’s needs in Japan in addition to those in Europe, Canada, Latin America, Australia and Asia. “Today’s announcement is a continuation of a very successful partnership between ICON and Lilly,” commented Peter Gray, chief executive officer at ICON. “Through our existing data management partnership, we have brought significant process efficienc...